3 Marijuana Stocks Moving On Recent News
The Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF) is presently the largest and most representative marijuana exchange traded fund on the markets. The ETF strives to duplicate, to an extent, the performance of the North American Marijuana Index. The index was designed to reveal the performance of a basket of North American life sciences companies with a large focus of business in the marijuana industry.
As of yesterday, since its initial trading date in April 2017, the marijuana ETF has yielded a return of 80 percent and is up 97 percent over the last trailing year. For comparison, the SPDR S&P500 ETF (SPY) gained about 14% during the same time period, while being just shy of 3 percent gains over the last year.
Horizons’ Marijuana Life Sciences ETF’s Top Holdings Include:
· Canopy Growth Corp. (CGC) (WEED) 11.48%
· Aurora Cannabis Inc. (ACB) (ACB.TO) 11.33%
· Tilray Inc. (TLRY) 10.98%
· Aphria Inc. (APHQF) (APH) 9.73%
· GW Pharmaceuticals Plc. (GWPH) 8.70%
· Scotts Miracle Grow Co. (SMG) 7.81%
· Cronos Group Inc. (CRON) (CRON.TO) 5.21%
· Hexo Corp. (HYYDF) (HEXO) 3.41%
· Canntrust Holdings Inc. (CNTTF) (TRST) 2.92%
· The Green Organic Dutchman Holdings (TGODF) (TGOD) 2.6%
As marijuana stocks continue to outperform the broad markets, here are a few companies to take a look at.
Integrated Cannabis Company (ICNAF) (ICAN.CN)
Integrated Cannabis develops, manufactures, and distributes botanically-based consumable products; offering a line of hemp-based CBD, and a THC, nutraceutical infused products under the X-SPRAYS brand, in which the company has a Letter of Intent completed for distribution throughout the clinics and doctors’ offices of Empower Clinics Inc. (CSE:EPW) and a Letter of Agreement for collaboration on X-SPRAYS products for the Canadian markets with GTEC Holdings Ltd, (GTEC) (GGTTF).
Today, Integrated Cannabis annouced an agreement to license all-natural vegan CBD formulated gummies and intends to begin distributing through its Arizona-based contract manufacturer, Titration Technologies.
“Our gummies will provide an approachable delivery method, that is easy to consume and with a great taste. We expect the bulk of the sales to take place online but also have plans to distribute through our existing networks to brick and mortar stores in Colorado and throughout the United States. We also plan to expand and introduce a product line of THC formulated gummies upon licensure approval”, said John Knapp, CEO.
The company has also recently announced signing a Letter of Intent to acquire all issued and outstanding securities of Colorado-based cannabis leader Critical Mass Industries, LLC, which possesses more than 100 elite cannabis strains. Integrated Cannabis entered into a retail focused collaboration with New Age Farm, Inc. (NF) (NWGFF) to deliver innovative CBD products and education this fall through pop-up stores in the Denver market. This news followed the announcement that
MedMen Enterprises, Inc. (MMNFF) (MMEN)
MedMen us leading cannabis company headquartered in the U.S. with assets and operations across the country. Most recently, a binding letter of intent was announced to purchase medical cannabis provider PharmaCann LLC in a stock deal valued at $682 million. The acquisition doubles the number of states where MedMen has licenses to 12 and combined, MedMen and PharmaCann would be licensed for 66 retail stores and 13 cultivation and production facilities.
Today, MedMen released earnings for Fourth Quarter and Fiscal Year 2018, highlights include:
· Enters Fiscal 2019 with leading US market position with 12 states, 67 retail stores and 14 factories with pending PharmaCann acquisition.
- Fourth quarter 2018 systemwide revenue was $20.6 million, up 1,317% from $1.5 million in fourth quarter 2017 and 44% from $14.3 million in third quarter 2018. The increase was primarily due to the majority of MedMen’s stores coming on line during the quarter.
- Fiscal year 2018 systemwide revenue was $39.8 million, up 1,390% from $2.7 million in fiscal year 2017.
Canopy Growth Corp. (CGC) (WEED)
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. The company’s focus, aside from servicing the Canadian market has been on expanding globally, with operations in 11 countries on five continents.
This morning, the company announced that TS Brandco, an indirect wholly-owned subsidiary of Canopy, purchased 10% of the issued and outstanding Class A common shares of 10006215 Manitoba Ltd., bringing TS Brandco’s total ownership of ManitobaCo to 89.9%. The transaction will further enhance Canopy subsidiaries’ market share of retail operations in the province of Manitoba.
This news followed the announcement of entering into an agreement to acquire the assets of ebbu, Inc., an Evergreen, Colorado -based hemp research company. The transaction will complement and accelerate multiple core verticals operating under Canopy Growth’s group of companies.
Small Cap Reporter is an affiliate of Midam Ventures LLC. Pursuant to an agreement between Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 2 months beginning September 4, 2018, and ending March 9, 2019. This payment has been increased to $75,000 per month for the period of November 4 2018 and ending March 9, 2019. Midam owns ZERO shares of Integrated Cannabis Company. Midam may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company. MarijuanaStocks.com, which is owned by MAPH Enterprises LLC., a Florida Corporation has been previously compensated $100,000 by a non-affiliate 3rd party for a 1 year period beginning August 1, 2017 and ending August 1, 2018 to publicly disseminate information about CNRP Mining, Inc. (CND.CN) (CRPGF) that is now Integrated Cannabis Company. MAPH owns zero shares. Click here for full Midam disclaimer.
r
